These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1576488)

  • 1. Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome.
    Rico H; Hernandez ER; Revilla M; Gómez-Castresana F
    Bone Miner; 1992 Feb; 16(2):131-8. PubMed ID: 1576488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
    Chesnut CH; Silverman S; Andriano K; Genant H; Gimona A; Harris S; Kiel D; LeBoff M; Maricic M; Miller P; Moniz C; Peacock M; Richardson P; Watts N; Baylink D
    Am J Med; 2000 Sep; 109(4):267-76. PubMed ID: 10996576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: a prospective study.
    Rico H; Revilla M; Hernández ER; Villa LF; Alvarez de Buergo M
    Calcif Tissue Int; 1995 Mar; 56(3):181-5. PubMed ID: 7750020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year calcitonin combination therapy for postmenopausal osteoporosis with crush fractures of the spine.
    Szücs J; Horváth C; Kollin E; Szathmári M; Holló I
    Calcif Tissue Int; 1992 Jan; 50(1):7-10. PubMed ID: 1739873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis syndromes: patient selection for calcitonin therapy.
    Avioli LV
    Geriatrics; 1992 Apr; 47(4):58, 61-4, 67. PubMed ID: 1555780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.
    Henriksen K; Byrjalsen I; Andersen JR; Bihlet AR; Russo LA; Alexandersen P; Valter I; Qvist P; Lau E; Riis BJ; Christiansen C; Karsdal MA;
    Bone; 2016 Oct; 91():122-9. PubMed ID: 27462009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin.
    Silverman SL
    Rheum Dis Clin North Am; 2001 Feb; 27(1):187-96. PubMed ID: 11285994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study.
    Lyritis GP; Tsakalakos N; Magiasis B; Karachalios T; Yiatzides A; Tsekoura M
    Calcif Tissue Int; 1991 Dec; 49(6):369-72. PubMed ID: 1818759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
    Ettinger B; Black DM; Mitlak BH; Knickerbocker RK; Nickelsen T; Genant HK; Christiansen C; Delmas PD; Zanchetta JR; Stakkestad J; Glüer CC; Krueger K; Cohen FJ; Eckert S; Ensrud KE; Avioli LV; Lips P; Cummings SR
    JAMA; 1999 Aug; 282(7):637-45. PubMed ID: 10517716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis.
    Lindsay R; Scheele WH; Neer R; Pohl G; Adami S; Mautalen C; Reginster JY; Stepan JJ; Myers SL; Mitlak BH
    Arch Intern Med; 2004 Oct; 164(18):2024-30. PubMed ID: 15477438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
    Meunier PJ; Sebert JL; Reginster JY; Briancon D; Appelboom T; Netter P; Loeb G; Rouillon A; Barry S; Evreux JC; Avouac B; Marchandise X
    Osteoporos Int; 1998; 8(1):4-12. PubMed ID: 9692071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of postmenopausal osteoporosis with low doses of calcitonin and a calcitonin-anabolic combination].
    Szücs J; Horváth C; Kollin E; Szathmári M; Holló I
    Orv Hetil; 1992 Jun; 133(23):1415-8. PubMed ID: 1603585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study.
    Lyritis GP; Ioannidis GV; Karachalios T; Roidis N; Kataxaki E; Papaioannou N; Kaloudis J; Galanos A
    Clin J Pain; 1999 Dec; 15(4):284-9. PubMed ID: 10617256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effectiveness and cost of treatment for vertebral fractures in women.
    Francis RM; Anderson FH; Torgerson DJ
    Br J Rheumatol; 1995 Dec; 34(12):1167-71. PubMed ID: 8608360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 5-year treatment with elcatonin and alfacalcidol on lumbar bone mineral density and the incidence of vertebral fractures in postmenopausal women with osteoporosis: a retrospective study.
    Iwamoto J; Takeda T; Ichimura S; Uzawa M
    J Orthop Sci; 2002; 7(6):637-43. PubMed ID: 12486466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in vertebral fracture risk in teriparatide-treated postmenopausal women as assessed by spinal deformity index.
    Genant HK; Siris E; Crans GG; Desaiah D; Krege JH
    Bone; 2005 Aug; 37(2):170-4. PubMed ID: 15961357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin therapy in osteoporosis.
    Muñoz-Torres M; Alonso G; Raya MP
    Treat Endocrinol; 2004; 3(2):117-32. PubMed ID: 15743107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
    Andrade SE; Majumdar SR; Chan KA; Buist DS; Go AS; Goodman M; Smith DH; Platt R; Gurwitz JH
    Arch Intern Med; 2003 Sep; 163(17):2052-7. PubMed ID: 14504118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.